ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,896Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 1171

$470K Total Retail Price of All Prescriptions

Rank: 243 out of 1171

381 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,797 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 477 355 1 5
AMLODIPINE BESYLATE 383 322 2 2
SIMVASTATIN 328 252 3 1
METFORMIN HCL 328 248 3 7
LEVOTHYROXINE SODIUM 324 293 5 4
LISINOPRIL 318 272 6 3
FUROSEMIDE 293 237 7 6
HYDROCODONE-ACETAMINOPHEN 285 178 S3 8 8
PRAVASTATIN SODIUM 245 211 9 13
HYDROCHLOROTHIAZIDE 244 221 10 9
METOPROLOL SUCCINATE 241 202 11 17
TRAMADOL HCL 215 152 12 18
ZOLPIDEM TARTRATE 197 153 13 21
LOSARTAN POTASSIUM 193 168 14 14
METOPROLOL TARTRATE 189 175 15 11
GABAPENTIN 188 150 16 16
ATORVASTATIN CALCIUM 157 113 17 10
POTASSIUM CHLORIDE 140 97 18 19
NEXIUM 139 124 19 25
LOSARTAN-HYDROCHLOROTHIAZIDE 136 121 20 40
BENAZEPRIL HCL 136 118 20 83
GLIMEPIRIDE 116 74 22 34
TAMSULOSIN HCL 114 98 23 28
WARFARIN SODIUM 108 101 24 12
CARVEDILOL 102 81 25 20
ACTOS 95 61 26 123
CLOPIDOGREL 92 81 27 35
PLAVIX 89 80 28 55
CITALOPRAM HBR 85 40 29 22
TRAZODONE HCL 76 46 30 37
OXYCODONE-ACETAMINOPHEN 62 25 S2 31 59
FLUOXETINE HCL 60 53 32 76
HYDRALAZINE HCL 60 57 32 60
SPIRONOLACTONE 58 41 34 53
SERTRALINE HCL 57 43 35 23
TRIAMTERENE-HCTZ 57 57 35 58
ATENOLOL 56 56 37 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 55 38 26
ISOSORBIDE MONONITRATE ER 55 52 38 44
ALLOPURINOL 53 53 40 31
FINASTERIDE 53 50 40 88
AMITRIPTYLINE HCL 52 24 R 42 74
CRESTOR 52 42 42 27
MELOXICAM 52 52 42 56
RAMIPRIL 51 23 45 85
PANTOPRAZOLE SODIUM 50 47 46 29
DILTIAZEM 24HR CD 50 34 46 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.